When it comes to the future of health care, one thing is clear: innovation isn’t optional—it’s inevitable. This September, WHX Tech arrives in Dubai with a clear mission: to bring together the leaders ...

The Trump administration is exploring a five-year pilot program to include weight-loss drugs like Wegovy, Ozempic, Zepbound, ...

The Health Resources and Services Administration has opened applications for a voluntary pilot program aimed at evaluating the 340B rebate model.  The 340B Program traditionally has offered up-front ...

Markets are assessing the reshaped US trade landscape after Trump on Thursday laid out steep new tariffs for dozens of countries.

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

By Ankur Banerjee SINGAPORE (Reuters) -Shares of European drugmakers slipped on Friday after U.S. President Donald Trump sent ...

Get the latest business headlines including Trump's demand for drug price cuts, Amazon's AI investments, and Open AI's ChatGPT updates.

Trial shows that risk of a major adverse cardiovascular event is eight per cent lower in people on new therapy ...

Eli Lilly is set to report Q2 2025 earnings on August 7, with consensus expecting $14.4 billion in revenue and $5.56 EPS, up 30-42% YoY. Learn more on LLY stock here.

Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.

Photo: Alamy President Donald Trump has sent letters to the leaders of 17 major pharmaceutical companies, urging them to take ...

At their peak last year, one share in the company Novo Nordisk cost $142; now, they can be bought for under $50.